Učitavanje...

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer

PURPOSE: The aim of the study was to evaluate the efficacy and safety of stereotactic body radiotherapy (SBRT) for pulmonary lesions in oligometastatic non‐small cell lung cancer (NSCLC) patients, to explore prognostic factors of progression‐free survival (PFS) and overall survival (OS), to validate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Ouyang, Wen, Yu, Jing, Nuerjiang, Shuake, Li, Zhijun, Wang, Dajiang, Wang, Xiaoyong, Zhang, Junhong, Xie, Conghua
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6712475/
https://ncbi.nlm.nih.gov/pubmed/31245933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2366
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!